Canada markets closed

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.5300+0.0100 (+0.66%)
At close: 04:00PM EDT
1.5000 -0.03 (-1.96%)
After hours: 07:17PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 191.72M
Enterprise Value 103.26M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.11
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.29

Trading Information

Stock Price History

Beta (5Y Monthly) 1.24
52-Week Change 3155.00%
S&P500 52-Week Change 322.36%
52 Week High 32.3100
52 Week Low 30.6000
50-Day Moving Average 31.4256
200-Day Moving Average 30.9813

Share Statistics

Avg Vol (3 month) 31.69M
Avg Vol (10 day) 31.73M
Shares Outstanding 5125.3M
Implied Shares Outstanding 6125.3M
Float 8117.48M
% Held by Insiders 10.06%
% Held by Institutions 119.21%
Shares Short (Apr 15, 2024) 412.35M
Short Ratio (Apr 15, 2024) 43.84
Short % of Float (Apr 15, 2024) 49.86%
Short % of Shares Outstanding (Apr 15, 2024) 49.86%
Shares Short (prior month Mar 15, 2024) 48.48M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 20, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Apr 20, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-17.84%
Return on Equity (ttm)-28.80%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -31.35M
Net Income Avi to Common (ttm)-30.09M
Diluted EPS (ttm)-0.2400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)88.46M
Total Cash Per Share (mrq)0.71
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)17.61
Book Value Per Share (mrq)0.73

Cash Flow Statement

Operating Cash Flow (ttm)-20.94M
Levered Free Cash Flow (ttm)-11.76M